Foreign Filer Report • Apr 30, 2019
Foreign Filer Report
Open in ViewerOpens in native device viewer
SEC FILE NUMBER 000-28996
(Check one): □ Form 10-K Form 20-F □ Form 11-K □ Form 10-Q □ Form 10-D □ Form N-SAR □ Form N-CSR For Period Ended: December 31, 2018
□ Transition Report on Form 10-K □ Transition Report on Form 20-F □ Transition Report on Form 11-K □ Transition Report on Form 10-Q □ Transition Report on Form N-SAR
For the Transition Period Ended: ____________________________
Read Instruction (on back page) Before Preparing Form. Please Print or Type. Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.
If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
Full Name of Registrant
______________________ Former Name if Applicable
Address of Principal Executive Office (Street and Number)
City, State and Zip Code
If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)
State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.
The Registrant is unable to file its Annual Report on Form 20-F for the year ended December 31, 2018 (the "2018 Form 20-F") on a timely basis without unreasonable effort or expense because of the complex nature of certain critical accounting estimates, including in connection with the completion of the sale of certain shares of Elbit Medical Technologies Ltd. (as detailed in Form 6- Ks filed by the Registrant on February 7, 2019, March 20, 2019 and March 28, 2019), which would require significant time and attention of management to complete were the Registrant required to file its 2018 Form 20-F prior to May 13, 2019.
(1) Name and telephone number of person to contact in regard to this notification
| PERRY WILDES | +972 | 3-6074475 |
|---|---|---|
| (Name) | (Area Code) | (Telephone Number) |
________________________________________________________________________________________________
(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed ? If the answer is no, identify report(s).
Yes No □
(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
Yes □ No
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
Date: APRIL 30, 2019 By: /s/Ron Hadassi
Name: RON HADASSI Title: CHIEF EXECUTIVE OFFICER
INSTRUCTION: The form may be signed by an executive officer of the registrant or by any other duly authorized representative. The name and title of the person signing the form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the representative's authority to sign on behalf of the registrant shall be filed with the form.
| ATTENTION |
|---|
| Intentional misstatements or omissions of fact constitute federal criminal violations (see 18 U.S.C. 1001). |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.